Personalized medicine and complementary and alternative medicine: In search of common grounds

Journal of Alternative and Complementary Medicine

Volumn 15, Issue 8, 2009, Pages 943-949

  Oguamanam, Chidi ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TOXIN;

ALTERNATIVE MEDICINE; ARTICLE; BIOMEDICINE; ENVIRONMENTAL STRESS; GENOMICS; GENOTYPE ENVIRONMENT INTERACTION; HEALTH CARE DELIVERY; HUMAN; MEDICAL CARE; PRIORITY JOURNAL;

ATTITUDE OF HEALTH PERSONNEL; COMPLEMENTARY THERAPIES; GENOMICS; HUMANS; INTEGRATIVE MEDICINE; PATIENT-CENTERED CARE;

EID: 70350123079     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2009.0056     Document Type: Article

References (32)

1. Oguamanam C. From rivalry to rapprochement: Biomedicine, complementary and alternative medicine at ethical crossroads. HEC [HealthCare Ethics Committee Forum] 2006;18:245-263.
2. Wolpe PR. Alternative medicine and the AMA. In: Baker RB, Latham SR, Emmanuel LL, eds. The American Medical Ethics Revolution: How the AMA's Code of Ethics has Transformed Physician's Relationship to Patients, Professionals and Society. Baltimore: John Hopkins University Press, 1999:218-239.
3. Barrett B. Alternative, complementary and conventional medicine: Is integration upon us? J Altern Complement Med 2003;9:417-427.
4. Shan Y, Busia K. Medical provisions in the twenty-first century. J Altern Complement Med 2002;8:193-196.
5. Geller G, Francomano CA. Complementary medicine and genetic medicine: Polar disciplines or dynamic partners? J Altern Complement Med 2005;11:343-347.
6. Barrett B, Marchard L, Scheder J, et al. Themes of holism, empowerment, access, and legitimacy define complementary, alternative medicine in relation to conventional medicine. J Altern Complement Med 2003;9:937-947.
7. Fulder S. Remembering the holistic view. J Altern Complement Med 2005;11:775-776.
8. Shealy CN. Holism in evolution. J Altern Complement Med 2003;9:333-334.
9. Watts S. Disease and Medicine in World History. New York: Routledge, 2003.
10. Rothman DJ, Marcus S, Kiceluk SA. Medicine and Western Civilization. New Brunswick, NJ: Rutgers University Press, 1995.
11. Hays JN. The Burdens of Disease: Epidemics and Response in Western History. New Brunswick, NJ: Rutgers University Press, 1998.
12. Hardy KJ. A view of the development of intestinal suture: Principles and techniques (part II). Neurosurgery 2003;52:3-19.
13. Watson JD. The Double Helix: A Personal Account of the Discovery and of the Structure of the DNA. New York: W.W. Norton, 1980.
14. Hsiao I-HJ. Patent protection for Chinese herbal product invention in Taiwan. J World Intellect Prop 2007;10:1-21.
15. Oguamanam C. Between reality and rhetoric: The epistemic schism in the recognition of traditional medicine in international law. St. Thomas Law Rev 2004;16:59-108.
16. Fulder S. The basic concepts of alternative medicine and their impact on our views of health. J Altern Complement Med 1998;4:147-158.
17. Collins FS. Personalized medicine: A new approach to staying well. The Boston Globe, July 17, 2005. Online document at: www.boston.com/news/globe/ editorial-opinion/ oped/articles/2005/07/17/personalized-medicine Accessed January 3, 2008.
18. HapMap Project. Online document at: www.hapmap.org/ thehapmap.html.en Accessed November 26, 2007.
19. Meadows M. Genomics and personalized medicine. FDA Consumer Magazine. Online document at: www.fda.gov/ fdac/features/2005/605-genomics.html Accessed December 12, 2007.
20. Collins FS. Personalized medicine: How the human genome era will usher in a health care revolution. Paper presented to the Personalized Medicine Coalition at the National Press Club, February 10, 2005. Online document at: www .genome.gov/Pages/News/webcasts/Personalized-Medicine- files/Default. htm#nopreload=1 Accessed December 12, 2007.
21. De Palma A. Pharmacogenomics and the brave new world of personalized medicine. Pharmaceutical Manufacturing. Online document at: http://www. pharmamanufacturing .com/articles/2006/047.html Accessed March 1, 2008.
22. Mattingly S. Really personalized medicine: The development of genomic makers to help diagnose disease and indicate treatment is ushering a new age. Techcom National J Technol Commercialization 2004;Nov-Dec:26-28.
23. ETC Group. Direct-to-consumer DNA testing and the myth of personalized medicine: Spit kits, SNP chips and human genomics. Special Report on Human Genomics, Part I. Online document at: www.etcgroup.org/en/materials/publications .html?pub-id=675 Accessed April 3, 2009.
24. Munroe JB. A coalition to drive personalized medicine. Personalized Med 2004;1:9-13.
25. CCS/NCIC (Canadian Cancer Society and National Cancer Institute of Canada) Position on the Patenting of BRACA1 and 2 Genes. Online document at: www.ncic.cancer.ca/vgn/ images/portal/cit-86751114/11/12/ 89486356postionstatements- BRCA1A-en.pdf Accessed March 2, 2008.
26. American Chemical Society. The promise of personalized medicine. Science Daily. Online document at: www .sciencedaily.com/releases/2004/09/040908082636. htm Accessed December 12, 2007.
27. Personalized Medicine Coalition. Online document at: www. personalizedmedicinecoalition.org/about/aboutpmc .php Accessed May 17, 2009.
28. Ruaño G. Quo vadis personalized? Personalized Med 2004; 1:1-7.
29. Olden K, Guthrie J. Genomics: Implication for toxicology: New frontiers. Mutation Res 2001;473:3-10.
30. Sharp L. Organ transplantation as a transformative experience: Anthropological insights into the restructuring of self. Med Anthropol Q (New Series) 1995;9:357-389.
31. Sylvia C, Novak D. A Change of Heart. New York: Little Brown & Co., 1997.
32. Sanner M. Living with stranger's organ: Views of the public and transplant recipients. Ann Transplant 2005;10:9-12.